Venetoclax and Decitabine in Pediatric Refractory T-cell Lymphoblastic Lymphoma
Conclusion:
This case highlights the potential clinical activity of venetoclax and decitabine in relapsed T-LL.
Source: Journal of Pediatric Hematology Oncology - Category: Hematology Tags: Online Articles: Clinical and Laboratory Observations Source Type: research
More News: Acute Leukemia | Acute Myeloid Leukemia | Cancer & Oncology | Hematology | Laboratory Medicine | Leukemia | Lymphoma | Pediatrics